Aquinox Pharmaceuticals (AQXP) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free AQXP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Aquinox Pharmaceuticals Short Interest DataCurrent Short Volume30,000 sharesPrevious Short Volume53,200 sharesChange Vs. Previous Month-43.61%Dollar Volume Sold Short$120,900.00Short Interest Ratio / Days to Cover0.3Last Record DateAugust 15, 2019Outstanding Shares23,540,000 sharesFloat Size23,390,000 sharesShort Percent of Float0.13%Today's Trading Volume346,901 sharesAverage Trading Volume239,362 sharesToday's Volume Vs. Average145% Short Selling Aquinox Pharmaceuticals ? Sign up to receive the latest short interest report for Aquinox Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAQXP Short Interest Over TimeAQXP Days to Cover Over TimeAQXP Percentage of Float Shorted Over Time Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. Aquinox Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/15/201930,000 shares $120,900.00 -43.6%0.1%0.3 $4.03 AQXP Short Interest - Frequently Asked Questions What is Aquinox Pharmaceuticals' current short interest? Short interest is the volume of Aquinox Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 30,000 shares of AQXP short. 0.13% of Aquinox Pharmaceuticals' shares are currently sold short. Learn More on Aquinox Pharmaceuticals' current short interest. What is a good short interest percentage for Aquinox Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.13% of Aquinox Pharmaceuticals' floating shares are currently sold short. Is Aquinox Pharmaceuticals' short interest increasing or decreasing? Aquinox Pharmaceuticals saw a decline in short interest in August. As of August 15th, there was short interest totaling 30,000 shares, a decline of 43.6% from the previous total of 53,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aquinox Pharmaceuticals' float size? Aquinox Pharmaceuticals currently has issued a total of 23,540,000 shares. Some of Aquinox Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aquinox Pharmaceuticals currently has a public float of 23,390,000 shares. How does Aquinox Pharmaceuticals' short interest compare to its competitors? 0.13% of Aquinox Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aquinox Pharmaceuticals: Mirum Pharmaceuticals, Inc. (17.32%), Deciphera Pharmaceuticals, Inc. (11.43%), Sage Therapeutics, Inc. (17.13%), Liquidia Co. (9.55%), Ligand Pharmaceuticals Incorporated (5.28%), Verve Therapeutics, Inc. (25.73%), Belite Bio, Inc (0.20%), Verona Pharma plc (8.01%), Collegium Pharmaceutical, Inc. (22.92%), Centessa Pharmaceuticals plc (2.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Netflix, Inc. ($6.50 billion), Fidelity National Information Services, Inc. ($5.01 billion), Charter Communications, Inc. ($4.02 billion), Microchip Technology Incorporated ($3.01 billion), Occidental Petroleum Co. ($2.16 billion), Omnicom Group Inc. ($2.03 billion), Block, Inc. ($2.00 billion), Global Payments Inc. ($1.76 billion), Match Group, Inc. ($1.66 billion), and Hormel Foods Co. ($1.66 billion). View all of the most shorted stocks. What does it mean to sell short Aquinox Pharmaceuticals stock? Short selling AQXP is an investing strategy that aims to generate trading profit from Aquinox Pharmaceuticals as its price is falling. AQXP shares are trading up $1.64 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aquinox Pharmaceuticals? A short squeeze for Aquinox Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AQXP, which in turn drives the price of the stock up even further. How often is Aquinox Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AQXP, twice per month. The most recent reporting period available is August, 15 2019. More Short Interest Resources from MarketBeat Related Companies: Mirum Pharmaceuticals Short Interest Data Deciphera Pharmaceuticals Short Interest Data Sage Therapeutics Short Interest Data Liquidia Short Interest Data Ligand Pharmaceuticals Short Interest Data Verve Therapeutics Short Interest Data Belite Bio Short Interest Data Verona Pharma Short Interest Data Collegium Pharmaceutical Short Interest Data Centessa Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AQXP) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company